Skip to main content
Shebli Atrash, MD, Oncology, Charlotte, NC, Atrium Health's Carolinas Medical Center

ShebliAtrashMDMS, FACP

Oncology Charlotte, NC

Hematologic Oncology

Atrium Health

Dr. Atrash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Atrash's full profile

Already have an account?

Summary

  • Dr. Shebli Atrash is an oncologist in Charlotte, NC and is affiliated with Atrium Health's Carolinas Medical Center. He received his medical degree from Damascus University Faculty of Medicine and has been in practice 13 years. He also speaks multiple languages, including Arabic. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.

Education & Training

  • University of Arkansas for Medical Sciences
    University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 2014 - 2017
  • St Barnabas Hospital
    St Barnabas HospitalResidency, Internal Medicine, 2008 - 2011
  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineClass of 2004

Certifications & Licensure

  • SC State Medical License
    SC State Medical License 2023 - 2025
  • NC State Medical License
    NC State Medical License 2017 - 2024
  • AR State Medical License
    AR State Medical License 2011 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dr. Atrash on Investigational Combinations with Venetoclax in Relapsed/Refractory Multiple Myeloma
    Dr. Atrash on Investigational Combinations with Venetoclax in Relapsed/Refractory Multiple MyelomaFebruary 10th, 2020
  • Dr. Atrash on the BELLINI Trial Results in Relapsed/Refractory Multiple Myeloma
    Dr. Atrash on the BELLINI Trial Results in Relapsed/Refractory Multiple MyelomaFebruary 3rd, 2020

Committees

  • Member, SWOG 2019 - Present
  • member, ACCRU 2019 - Present
  • Member, International Myeloma Working Group 2019 - Present

Professional Memberships

Other Languages

  • Arabic

Hospital Affiliations